サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542926

皮膚鏡デバイスの世界市場：2024年～2031年

Global Dermatoscope Devices Market - 2024-2031

出版日
ページ情報
英文 187 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
皮膚鏡デバイスの世界市場：2024年～2031年
出版日: 2024年08月26日
発行: DataM Intelligence
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

市場概要

皮膚鏡デバイスの世界市場は、2023年に9億7,129万米ドルに達し、2031年には19億3,089万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは9.2%で成長する見込みです。

皮膚鏡装置は、皮膚を詳細に検査するために使用される特殊な医療機器です。皮膚病変、ほくろ、その他の皮膚異常の拡大像を提供し、肉眼では見えない表面および表面下の構造をよりよく可視化することができます。皮膚鏡の主な目的は、良性病変、炎症性皮膚疾患、感染症だけでなく、皮膚がんを含む様々な皮膚疾患の早期発見、診断、モニタリングに役立つことです。

皮膚鏡は通常、拡大レンズシステムで構成され、多くの場合、偏光または非偏光の光源を備え、まぶしさを軽減し、皮膚構造の視認性を高めるのに役立っています。また、一部の皮膚鏡にはデジタル画像処理機能が搭載されており、文書化、分析、遠隔診察の目的で高解像度の画像を撮影・保存することができます。これらの機器には、携帯用のハンドヘルド型や、より包括的な検査用のデスクトップ型など、さまざまな形態があります。診断精度の向上、生検判断の指針、治療反応のモニタリングにおいて重要な役割を果たしています。

市場力学：

促進要因

皮膚内視鏡の進歩の高まり

皮膚内視鏡機器の進歩が進んでおり、予測期間中に市場を牽引するとみられます。先進的な皮膚内視鏡装置には、偏光および非偏光光源、交差偏光、調整可能な拡大レベルなどの機能が組み込まれており、皮膚病変のより良い可視化と特徴付けを可能にしています。これにより、特に良性病変と悪性病変の区別において診断精度が向上します。

さらに、一部の先進的な皮膚内視鏡は、自動病変分析と意思決定支援のために人工知能（AI）アルゴリズムを活用しています。AIを搭載した機能は、病変の分類、リスク層別化、治療推奨を支援し、ヘルスケア提供者の専門知識を補完し、診断結果を改善する可能性があります。

例えば、2024年1月17日、民間の機器メーカーDermaSensor社は、人工知能を使用して皮膚がんを検出する携帯型機器の米国食品医薬品局の承認をクリアしました。マイアミに本拠を置く非公開会社の装置（DermaSensorとも呼ばれる）は、光とAIを搭載したアルゴリズムを利用し、プライマリ・ケア医が疑わしいほくろや病変にがんが存在するかどうかを識別するのに役立ちます。

最近の皮膚鏡の多くはデジタル画像処理機能を備えており、高解像度の画像キャプチャと保存が可能です。電子カルテや遠隔医療プラットフォームとの統合により、シームレスな文書化、分析、遠隔診察が容易になり、ワークフローの効率と患者のケアが強化されます。

さらに、様々な皮膚がんや皮膚疾患の有病率の増加、新規デバイスに対するFDA承認の増加、皮膚鏡デバイスに関する認知度の向上、より多くの皮膚鏡デバイス開拓における技術進歩の増加が、予測期間にわたって市場を牽引すると予想される要因です。

抑制要因

代替方法への嗜好、皮膚鏡機器に関連する高コスト、規制上の課題、皮膚鏡機器に関する限られた認知度、これらの機器に関連する技術的課題などの要因が市場を阻害すると予想される要因です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 皮膚鏡デバイスの進歩
    • 抑制要因
      • 機器の高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ
  • PESTEL分析
  • 特許分析
  • SWOT分析

第6章 COVID-19分析

第7章 製品タイプ別

  • デジタル皮膚鏡
  • ハイブリッド皮膚鏡
  • 接触式皮膚鏡
  • 非接触型皮膚鏡

第8章 モダリティ別

  • ハンドヘルド皮膚鏡
  • 卓上型皮膚鏡

第9章 用途別

  • 皮膚疾患診断
  • 皮膚病変検査
  • その他

第10章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 皮膚科センター
  • 診断センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • HEINE Optotechnik GmbH & Co. KG
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Optilia Medical
  • FotoFinder Systems GmbH
  • Rudolf Riester GmbH
  • Canfield Scientific, Inc.
  • Firefly Global
  • Illuco Co., Ltd.
  • DermLite
  • HILLROM & WELCH ALLYN
  • KRUPA MEDI SCAN（LIST NOT EXHAUSTIVE）

第14章 付録

目次
Product Code: MD1285

Market Overview

The Global Dermatoscope Devices Market reached US$ 971.29 million in 2023 and is expected to reach US$ 1,930.89 million by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.

Dermatoscope devices are specialized medical instruments used to examine the skin in detail. They provide magnified views of skin lesions, moles and other skin abnormalities, enabling better visualization of surface and subsurface structures that may not be visible to the naked eye. The primary purpose of dermatoscopes is to aid in the early detection, diagnosis and monitoring of various skin conditions, including skin cancer, as well as benign lesions, inflammatory skin diseases and infectious conditions.

Dermatoscope devices typically consist of a magnifying lens system, often with polarized or non-polarized light sources, which help to reduce glare and enhance the visibility of skin structures. Some dermatoscopes also incorporate digital imaging capabilities, allowing for the capture and storage of high-resolution images for documentation, analysis and remote consultation purposes. These devices come in various forms, including handheld models for portable use and desktop models for more comprehensive examinations. They play a crucial role in improving diagnostic accuracy, guiding biopsy decisions and monitoring treatment responses.

Market Dynamics: Drivers

Rising advancements in dermatoscope devices

The rising advancements in dermatoscope devices are expected to drive the market over the forecast period. Advanced dermatoscope devices incorporate features such as polarized and non-polarized light sources, cross-polarization and adjustable magnification levels, allowing for better visualization and characterization of skin lesions. This leads to increased diagnostic accuracy, particularly in distinguishing between benign and malignant lesions.

Additionally, some advanced dermatoscope devices leverage artificial intelligence (AI) algorithms for automated lesion analysis and decision support. AI-powered features aid in lesion classification, risk stratification and treatment recommendations, complementing the expertise of healthcare providers and potentially improving diagnostic outcomes.

For instance, on January 17, 2024, Privately-held device maker DermaSensor cleared the U.S. Food and Drug Administration approvals for its hand-held device that uses artificial intelligence to detect skin cancer. The Miami-based private company's device - also called DermaSensor - utilizes light and an AI-powered algorithm to help primary care physicians in identifying the presence of cancer in suspicious moles or lesions.

Many modern dermatoscope devices are equipped with digital imaging capabilities, enabling high-resolution image capture and storage. Integration with electronic health records and telemedicine platforms facilitates seamless documentation, analysis and remote consultation, enhancing workflow efficiency and patient care.

Further, the increasing prevalence of various skin cancers and skin diseases, rising FDA approvals for novel devices, increasing awareness about dermatoscope devices and increasing technological advancements in the development of more dermatoscope devices are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the preference for alternative methods, high cost associated with dermatoscope devices, regulatory challenges, limited awareness about dermatoscope devices and technical challenges associated with these devices are the factors expected to hamper the market.

Segment Analysis

The global dermatoscope devices market is segmented based on product type, modality, application, end-user and region.

The digital dermatoscope segment accounted for approximately 39.4% of the dermatoscope devices market share

The digital dermatoscope segment is expected to hold the largest market share over the forecast period. Digital dermatoscopes capture high-resolution images of skin lesions, providing detailed and accurate visual documentation. These images can be magnified, manipulated and stored for further analysis, making them invaluable for monitoring lesion changes over time and facilitating remote consultations.

For instance, on June 6, 2023, DeepX Diagnostics received clearance from the US Food and Drug Administration (FDA) for its digital dermatoscope DermoSight for teledermatology screening of suspect skin cancer lesions in the United States. DermoSight is currently cleared to acquire skin lesion images for teledermatology assessment, like existing digital dermatoscopes. It is also designed for integration with an AI algorithm, empowered by proprietary optical transfer diagnosis (OTD) technology, although the FDA has yet to approve the commercial use of the OTD technology with DermoSight. OTD enables the analysis of lesions on the sub-skin level based on their light-transferring properties. The technology is designed to turn dermatoscopic assessment into a robust, non-invasive and accessible AI-driven tool and to streamline and fast-track skin cancer diagnosis.

Digital dermatoscopes often incorporate advanced features such as polarized or non-polarized light, adjustable magnification and image enhancement algorithms, which enhance the visualization of surface and subsurface structures of the skin. This allows for better characterization of lesions and improves diagnostic accuracy. These devices also enables patients to actively participate in their care by allowing them to view and discuss their skin images with healthcare providers.

Geographical Analysis

North America accounted for approximately 41.3% of the market share

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and rising demand for dermatoscope devices. North America especially the United States is known hub for its strong presence of major players such as medical device companies. This presence of major players in the region aims to develop more technologically advanced dermatoscope devices through digital features and AI algorithms.

In addition, there is an increasing demand for dermatoscope devices due to the increasing prevalence of skin cancers in the region especially in the United States. For instance, according to the American Academy of Dermatology Association, skin cancer is the most common cancer in the United States. Current estimates are that one in five Americans will develop skin cancer in their lifetime. It is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. Research estimates that nonmelanoma skin cancer (NMSC), including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), affects more than 3 million Americans a year. More than 1 million Americans are living with melanoma.

Competitive Landscape

The major global players in the dermatoscope devices market include HEINE Optotechnik GmbH & Co. KG, Optilia Medical, FotoFinder Systems GmbH, Rudolf Riester GmbH, Canfield Scientific, Inc., Firefly Global, Illuco Co., Ltd., DermLite, HILLROM & WELCH ALLYN and KRUPA MEDI SCAN among others.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global dermatoscope devices market. The COVID-19 pandemic has caused a massive shift towards telehealth, including teledermatology and teledermoscopy, making these devices more relevant. There have been several studies evaluating patient-directed dermoscopy during a self-skin examination. Some patients postponed seeking medical attention for skin concerns during the pandemic, either due to fear of contracting the virus or logistical challenges associated with accessing healthcare services. As a result, there may have been delays in the diagnosis and treatment of skin conditions, including skin cancer, which could impact the demand for dermatoscope devices in the short term.

Why Purchase the Report?

  • To visualize the global dermatoscope devices market segmentation based on product type, modality, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of dermatoscope devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global dermatoscope devices market report would provide approximately 69 tables, 72 figures, and 187 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Modality
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Advancements in Dermatoscope Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of the Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Digital Dermatoscope*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hybrid Dermatoscope
  • 7.4. Contact Dermatoscope
  • 7.5. Noncontact Dermatoscope

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Handheld Dermatoscopes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Desktop Dermatoscopes

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Skin Disease Diagnosis*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Examination of Skin Lesions
  • 9.4. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Clinics
  • 10.4. Dermatology Centers
  • 10.5. Diagnostic Centers
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. HEINE Optotechnik GmbH & Co. KG*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Optilia Medical
  • 13.3. FotoFinder Systems GmbH
  • 13.4. Rudolf Riester GmbH
  • 13.5. Canfield Scientific, Inc.
  • 13.6. Firefly Global
  • 13.7. Illuco Co., Ltd.
  • 13.8. DermLite
  • 13.9. HILLROM & WELCH ALLYN
  • 13.10. KRUPA MEDI SCAN (LIST NOT EXHAUSTIVE)

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us